Page last updated: 2024-10-21

1-(3-chlorophenyl)piperazine and Bulimia Nervosa

1-(3-chlorophenyl)piperazine has been researched along with Bulimia Nervosa in 1 studies

1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure
1-(3-chlorophenyl)piperazine : A N-arylpiperazine that is piperazine carrying a 3-chlorophenyl substituent at position 1. It is a metabolite of the antidepressant drug trazodone.

Bulimia Nervosa: An eating disorder that is characterized by a cycle of binge eating (BULIMIA or bingeing) followed by inappropriate acts (purging) to avert weight gain. Purging methods often include self-induced VOMITING, use of LAXATIVES or DIURETICS, excessive exercise, and FASTING.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruce, KR1
Steiger, H1
Joober, R1
Ng Ying Kin, NM1
Israel, M1
Young, SN1

Trials

1 trial available for 1-(3-chlorophenyl)piperazine and Bulimia Nervosa

ArticleYear
Association of the promoter polymorphism -1438G/A of the 5-HT2A receptor gene with behavioral impulsiveness and serotonin function in women with bulimia nervosa.
    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2005, Aug-05, Volume: 137B, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Body Mass Index; Bulimia Nervosa; Female; Genotype; Humans;

2005